0000313616-19-000176.txt : 20191218 0000313616-19-000176.hdr.sgml : 20191218 20191218085059 ACCESSION NUMBER: 0000313616-19-000176 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20191218 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20191218 DATE AS OF CHANGE: 20191218 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DANAHER CORP /DE/ CENTRAL INDEX KEY: 0000313616 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL [3823] IRS NUMBER: 591995548 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08089 FILM NUMBER: 191291404 BUSINESS ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE. N.W. STREET 2: SUITE 800W CITY: WASHINGTON STATE: DC ZIP: 20037-1701 BUSINESS PHONE: 2028280850 MAIL ADDRESS: STREET 1: 2200 PENNSYLVANIA AVE. N.W. STREET 2: SUITE 800W CITY: WASHINGTON STATE: DC ZIP: 20037-1701 FORMER COMPANY: FORMER CONFORMED NAME: DMG INC DATE OF NAME CHANGE: 19850221 8-K 1 newdhr8-k.htm 8-K Document
false0000313616 0000313616 2019-12-18 2019-12-18 0000313616 dhr:A1.35SeniorNotesDue2039Member 2019-12-18 2019-12-18 0000313616 dhr:A2.5SeniorNotesDue2025Member 2019-12-18 2019-12-18 0000313616 dhr:A0.45SeniorNotesDue2028Member 2019-12-18 2019-12-18 0000313616 us-gaap:PreferredStockMember 2019-12-18 2019-12-18 0000313616 dhr:A1.8SeniorNotesDue2049Member 2019-12-18 2019-12-18 0000313616 us-gaap:CommonStockMember 2019-12-18 2019-12-18 0000313616 dhr:A1.7SeniorNotesDue2022Member 2019-12-18 2019-12-18 0000313616 dhr:A1.2SeniorNotesDue2027Member 2019-12-18 2019-12-18 0000313616 dhr:A0.75SeniorNotesDue2031Member 2019-12-18 2019-12-18 0000313616 dhr:FloatingRateSeniorNotesDue2022Member 2019-12-18 2019-12-18 0000313616 dhr:A0.2SeniorNotesDue2026Member 2019-12-18 2019-12-18


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
FORM 8-K
__________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported): December 18, 2019
__________________
dhrlogofor8ksa34.jpg
DANAHER CORPORATION
 
(Exact Name of Registrant as Specified in Its Charter)
 
__________________
Delaware
 
001-08089
 
59-1995548
(State or Other Jurisdiction of Incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)
 
 
 
 
2200 Pennsylvania Avenue, NW
 
 
 
20037-1701
Suite 800W
 
 
 
Washington,
DC
 
 
 
(Address of Principal Executive Offices)
 
 
 
(Zip Code)
202-828-0850
(Registrant’s Telephone Number, Including Area Code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
__________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))




Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common stock, $0.01 par value
DHR
New York Stock Exchange
4.75% Mandatory Convertible Preferred Stock, Series A, without par value
DHR.PRA
New York Stock Exchange
Floating Rate Senior Notes due 2022
DHR F 06/30/22
New York Stock Exchange
1.700% Senior Notes due 2022
DHR 1.7 01/04/22
New York Stock Exchange
2.500% Senior Notes due 2025
DHR 2.5 07/08/25
New York Stock Exchange
0.200% Senior Notes due 2026
DHR 0.2 03/18/26
New York Stock Exchange
1.200% Senior Notes due 2027
DHR 1.2 06/30/27
New York Stock Exchange
0.450% Senior Notes due 2028
DHR 0.45 03/18/28
New York Stock Exchange
0.750% Senior Notes due 2031
DHR 0.75 09/18/31
New York Stock Exchange
1.350% Senior Notes due 2039
DHR 1.35 09/18/39
New York Stock Exchange
1.800% Senior Notes due 2049
DHR 1.8 09/18/49
New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
 
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 




ITEM 7.01
 
REGULATION FD DISCLOSURE
On December 18, 2019, Danaher Corporation (“Danaher” or the “Company”) completed the disposition of its remaining interest in Envista Holdings Corporation (“Envista”). The Company’s Annual Report on Form 10-K for the year ending December 31, 2019 will be its first periodic report to reflect Envista as a discontinued operation. To assist investors in assessing Danaher’s historical and forecasted performance on a basis that excludes the results of operations of Envista, Danaher has furnished herewith as Exhibit 99.1 and incorporated by reference herein, unaudited financial data of Danaher prepared in accordance with, or on a basis consistent with, Article 11 of Regulation S-X, and non-GAAP adjusted financial data of Danaher, for the periods reflected therein.
The information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished by Danaher and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such as filing.
ITEM 9.01
 
FINANCIAL STATEMENTS AND EXHIBITS
 
 
 
(d)
 
Exhibits
 
 
 
Exhibit No.
 
Description
99.1
 
104
 
Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101)




SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
DANAHER CORPORATION
 
 
 
 
Date:
December 18, 2019
By:
/s/ Matthew R. McGrew
 
 
 
Matthew R. McGrew
 
 
 
Executive Vice President and Chief Financial Officer


 EX-99.1 2 ex991-unauditedproform.htm EXHIBIT 99.1 Exhibit
Exhibit 99.1

OVERVIEW
On December 18, 2019, Danaher Corporation (“Danaher”, the “Company” or “we”), completed the disposition of its remaining 80.6% ownership interest in Envista Holdings Corporation (“Envista”). As the disposition was completed during the fourth quarter of 2019, the Company will classify Envista as a discontinued operation in its historical financial statements beginning in the fourth quarter of 2019.
Danaher is providing the below unaudited pro forma statements of earnings data and non-GAAP financial data of the Company for the fiscal years ended December 31, 2018 and 2017, the nine-month period ended September 27, 2019 and the fiscal quarters ended March 29, 2019, June 28, 2019, September 27, 2019, March 30, 2018, June 29, 2018, September 28, 2018 and December 31, 2018 to assist investors in assessing Danaher’s historical performance on a basis that excludes Envista’s results of operations.
•
Table 1: In Table 1, the Pro Forma and Non-GAAP Pro Forma Consolidated Statements of Earnings Data for Danaher expands upon the Article 11 Pro Forma Financial Statements to include information reflecting Danaher’s quarterly results for 2019 and 2018 on a basis that excludes Envista’s results of operations. While these quarterly results are not required under Article 11 of Regulation S-X and are therefore non-GAAP financial information, they have been presented in a manner consistent with the Article 11 Pro Forma Financial Statements.
•
Table 2: In Table 2, the Company presents the non-GAAP measure of adjusted pro forma diluted net earnings per share from continuing operations on a basis that excludes Envista’s results of operations. The Company reconciles this measure by using Danaher’s pro forma (or in the case of the quarterly results, non-GAAP pro forma) diluted net earnings per share from continuing operations excluding Envista for the periods presented (prepared in a manner consistent with the Article 11 Pro Forma Financial Statements) as a starting point and then eliminating each of the adjustment items identified below to yield non-GAAP adjusted pro forma diluted net earnings per share from continuing operations excluding Envista.
•
Table 3: In Table 3, the Company presents the Adjusted Average Diluted Common Shares Outstanding on a basis that adjusts for the conversion of Danaher’s Mandatory Convertible Preferred Stock (“MCPS”) for each of the periods presented.
•
Table 4: In Table 4, the Company presents its pro forma and non-GAAP pro forma sales, operating profit, depreciation and amortization at both the consolidated Company level and segment level on a basis that excludes Envista.
•
Table 5: In Table 5, the Company presents the non-GAAP measure of Core Revenue Growth on a basis that excludes Envista from all periods.
•
Table 6: In Table 6, the Company presents its previously communicated earnings guidance which was issued October 24, 2019, for both the three-month period and year ending December 31, 2019, on a basis that excludes Envista from all periods.



1

Table 1: Pro Forma and Non-GAAP Pro Forma Consolidated Statements of Earnings Data for Danaher Corporation Reflecting Envista Holdings Corporation (Disposed on December 18, 2019) as a Discontinued Operation
($ and shares in millions, except per share amounts)
Nine-Month Period Ended
 
Three-Month Period Ended 1
 
Year Ended
 
Three-Month Period Ended 1
 
Year Ended
 
Sep 27, 2019
 
Sep 27, 2019
 
Jun 28, 2019
 
Mar 29, 2019
 
Dec 31, 2018
 
Dec 31, 2018
 
Sep 28, 2018
 
Jun 29, 2018
 
Mar 30, 2018
 
Dec 31, 2017
Sales
$
13,042.7

 
$
4,378.0

 
$
4,444.5

 
$
4,220.2

 
$
17,048.5

 
$
4,604.5

 
$
4,173.6

 
$
4,247.6

 
$
4,022.8

 
$
15,518.8

Cost of sales
(5,762.6
)
 
(1,936.6
)
 
(1,960.7
)
 
(1,865.3
)
 
(7,543.2
)
 
(2,070.8
)
 
(1,864.0
)
 
(1,853.7
)
 
(1,754.7
)
 
(6,947.5
)
Gross profit
7,280.1

 
2,441.4

 
2,483.8

 
2,354.9

 
9,505.3

 
2,533.7

 
2,309.6

 
2,393.9

 
2,268.1

 
8,571.3

Operating costs:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Selling, general and administrative expenses
(4,140.2
)
 
(1,382.5
)
 
(1,390.0
)
 
(1,367.7
)
 
(5,391.0
)
 
(1,394.3
)
 
(1,305.4
)
 
(1,367.7
)
 
(1,323.6
)
 
(5,042.6
)
Research and development expenses
(832.2
)
 
(282.6
)
 
(282.1
)
 
(267.5
)
 
(1,059.2
)
 
(276.0
)
 
(258.9
)
 
(267.3
)
 
(257.0
)
 
(956.4
)
Operating profit
2,307.7

 
776.3

 
811.7

 
719.7

 
3,055.1

 
863.4

 
745.3

 
758.9

 
687.5

 
2,572.3

Nonoperating income (expense):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other income, net
14.3

 
4.2

 
5.0

 
5.1

 
34.5

 
11.2

 
7.6

 
8.1

 
7.6

 
103.5

Interest expense
(64.2
)
 
(24.0
)
 
(19.7
)
 
(20.5
)
 
(136.9
)
 
(29.6
)
 
(35.8
)
 
(37.8
)
 
(33.7
)
 
(140.1
)
Interest income
72.0

 
30.1

 
26.2

 
15.7

 
9.2

 
2.5

 
2.8

 
2.5

 
1.4

 
7.5

Earnings from continuing operations before income taxes
2,329.8

 
786.6

 
823.2

 
720.0

 
2,961.9

 
847.5

 
719.9

 
731.7

 
662.8

 
2,543.2

Income taxes
(690.4
)
 
(155.9
)
 
(146.8
)
 
(387.7
)
 
(555.6
)
 
(163.7
)
 
(119.6
)
 
(138.9
)
 
(133.4
)
 
(371.0
)
Net earnings from continuing operations
1,639.4

 
630.7

 
676.4

 
332.3

 
2,406.3

 
683.8

 
600.3

 
592.8

 
529.4

 
2,172.2

Net earnings from discontinued operations, net of income taxes
93.7

 
37.3

 
54.9

 
1.5

 
244.6

 
63.0

 
63.4

 
81.0

 
37.2

 
319.9

Net earnings
1,733.1

 
668.0

 
731.3

 
333.8

 
2,650.9

 
746.8

 
663.7

 
673.8

 
566.6

 
2,492.1

Mandatory convertible preferred stock dividends
(48.8
)
 
(19.6
)
 
(22.7
)
 
(6.5
)
 
—

 
—

 
—

 
—

 
—

 
—

Net earnings attributable to common stockholders
$
1,684.3

 
$
648.4

 
$
708.6

 
$
327.3

 
$
2,650.9

 
$
746.8

 
$
663.7

 
$
673.8

 
$
566.6

 
$
2,492.1

Pro forma net earnings per common share from continuing operations 2:
 
 
 
 
 
 
 
 
 
 
 
 
Basic
$
2.23

A 
$
0.85

 
$
0.91

 
$
0.46

 
$
3.43

A 
$
0.97

 
$
0.86

 
$
0.85

 
$
0.76

 
$
3.12

Diluted
$
2.20

A 
$
0.84

 
$
0.90

 
$
0.45

 
$
3.39

A 
$
0.96

 
$
0.85

 
$
0.84

 
$
0.75

 
$
3.08

Pro forma net earnings per common share from discontinued operations:
 
 
 
 
 
 
 
 
 
 
 
 
Basic
$
0.13

 
$
0.05

 
$
0.08

 
$
—

 
$
0.35

 
$
0.09

 
$
0.09

 
$
0.12

 
$
0.05

 
$
0.46

Diluted
$
0.13

 
$
0.05

 
$
0.08

 
$
—

 
$
0.34

 
$
0.09

 
$
0.09

 
$
0.11

 
$
0.05

 
$
0.45

Pro forma net earnings per common share 3:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic
$
2.36

A 
$
0.90

 
$
0.99

 
$
0.46

 
$
3.78

 
$
1.06

 
$
0.95

 
$
0.96

B 
$
0.81

 
$
3.58

Diluted
$
2.32

B 
$
0.89

 
$
0.97

B 
$
0.46

B 
$
3.74

A, B 
$
1.05

 
$
0.93

B 
$
0.95

 
$
0.80

 
$
3.53

Pro forma average common stock and common equivalent shares outstanding:
 
 
 
 
 
 
 
 
 
 
 
 
Basic
714.7

 
718.8

 
717.6

 
708.0

 
700.6

 
702.2

 
701.4

 
700.2

 
698.6

 
695.8

Diluted
725.2

 
729.3

 
727.9

 
718.5

 
710.2

 
711.2

 
710.6

 
709.5

 
709.5

 
706.1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1  These quarterly results are not required under Article 11 of Regulation S-X and are therefore non-GAAP financial information. The quarterly results have been presented in a manner consistent with the Article 11 Pro Forma Financial Statements.
2  Pro forma net earnings per common share from continuing operations is calculated as net earnings from continuing operations less the MCPS dividends for the quarterly and year-to-date periods ending in 2019, plus the interest on the Company’s convertible liquid yield option notes (“LYONs”) for all periods presented above.
3  Pro forma net earnings per common share is calculated as net earnings from common stockholders plus the interest on the Company’s LYONs for all periods presented above.
A Pro forma net earnings per common share amounts do not add across to the nine-month or year-ended amounts due to rounding.
B Pro forma net earnings per common share amount does not add due to rounding.
 
 
 
 
 
 
 
 
 
 
 
 

2

Table 2: Reconciliation of Pro Forma and Non-GAAP Pro Forma Diluted Net Earnings Per Share from Continuing Operations (Reflecting Envista Holdings Corporation (Disposed on December 18, 2019) as a Discontinued Operation) to Adjusted Pro Forma Diluted Net Earnings Per Share from Continuing Operations (Non-GAAP)
 
Nine-Month Period Ended
 
Three-Month Period Ended 1
 
Year Ended
 
Three-Month Period Ended 1
 
Year Ended
 
Sep 27, 2019 2
 
Sep 27, 2019 2
 
Jun 28, 2019 2
 
Mar 29, 2019 2
 
Dec 31, 2018
 
Dec 31, 2018
 
Sep 28, 2018
 
Jun 29, 2018
 
Mar 30, 2018
 
Dec 31, 2017
Pro Forma (or non-GAAP pro forma as applicable) Diluted Net Earnings per Common Share from Continuing Operations Excluding Envista
$2.20
*
$0.84
 
$0.90
 
$0.45
 
$3.39
*
$0.96
 
$0.85
 
$0.84
 
$0.75
 
$3.08
Pretax amortization of acquisition-related intangible assets A
0.64
 
0.21
 
0.21
 
0.22
 
0.87
*
0.22
 
0.21
 
0.22
 
0.21
 
0.82
Pretax transaction costs deemed significant and integration preparation costs related to the anticipated GE Biopharma acquisition B
0.09
 
0.04
 
0.03
 
0.02
 
—
 
—
 
—
 
—
 
—
 
—
Pretax acquisition-related transaction costs deemed significant and fair value adjustments to inventory, in each case related to the acquisition of IDT and incurred in the second quarter of 2018 C
—
 
—
 
—
 
—
 
0.02
 
—
 
—
 
0.02
 
—
 
—
Pretax gain on resolution of acquisition-related matters recognized in the second quarter of 2018 and fourth quarter of 2017 D
—
 
—
 
—
 
—
 
(0.01)
 
—
 
—
 
(0.01)
 
—
 
(0.02)
Pretax gain on sale of investments in 2017 E
—
 
—
 
—
 
—
 
—
 
—
 
—
 
—
 
—
 
(0.10)
Pretax restructuring, impairment and other related charges recorded in 2017 F
—
 
—
 
—
 
—
 
—
 
—
 
—
 
—
 
—
 
0.11
Tax effect of all adjustments reflected above G
(0.13)
*
(0.04)
 
(0.04)
 
(0.04)
 
(0.17)
 
(0.04)
 
(0.04)
 
(0.05)
 
(0.04)
 
(0.15)
Discrete tax adjustments and other tax-related adjustments H
0.31
*
—
 
(0.02)
 
0.34
 
(0.05)
*
—
 
(0.03)
 
(0.01)
 
—
 
(0.19)
Declared dividends on the MCPS assuming “if-converted” method I
0.03
*
0.01
 
0.01
 
—
 
—
 
—
 
—
 
—
 
—
 
—
Effects of rounding
—
 
—
 
—
 
—
 
—
*
—
 
(0.01)
 
—
 
—
 
(0.01)
Adjusted Pro Forma Diluted Net Earnings per Common Share from Continuing Operations Excluding Envista (non-GAAP)
$3.14
 
$1.06
 
$1.09
 
$0.99
 
$4.05
 
$1.14
 
$0.98
 
$1.01
 
$0.92
 
$3.54
1 These quarterly results are not required under Article 11 of Regulation S-X and are therefore non-GAAP financial information. The quarterly results have been presented in a manner consistent with the Article 11 Pro Forma Financial Statements.
2 For each of the quarterly periods and the nine-month period ending in 2019, each of the per share amounts above have been calculated assuming the MCPS had been converted into shares of common stock.
* Quarterly amounts do not add across to the nine-month or year-ended amounts due to rounding.

3

A
Amortization of acquisition-related intangible assets in the following historical periods ($ in millions) (only the pretax amounts excluding Envista set forth below are reflected in the amortization line item above):
 
Nine-Month Period Ended
 
Three-Month Period Ended
 
Year Ended
 
Three-Month Period Ended
 
Year Ended
($ in millions)
Sep 27, 2019
 
Sep 27, 2019
 
Jun 28, 2019
 
Mar 29, 2019
 
Dec 31, 2018
 
Dec 31, 2018
 
Sep 28, 2018
 
Jun 29, 2018
 
Mar 30, 2018
 
Dec 31, 2017
Pretax amortization including Envista
$
536.6

 
$
177.9

 
$
178.8

 
$
179.9

 
$
706.2

 
$
178.7

 
$
174.1

 
$
181.1

 
$
172.3

 
$
660.5

Less Envista amortization
(67.3
)
 
(22.3
)
 
(22.5
)
 
(22.5
)
 
(90.6
)
 
(22.6
)
 
(22.5
)
 
(22.6
)
 
(22.9
)
 
(81.7
)
Pretax amortization from continuing operations excluding Envista
$
469.3

 
$
155.6

 
$
156.3

 
$
157.4

 
$
615.6

 
$
156.1

 
$
151.6

 
$
158.5

 
$
149.4

 
$
578.8

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
After-tax amortization from continuing operations excluding Envista
$
379.0

 
$
126.1

 
$
126.1

 
$
126.8

 
$
494.5

 
$
125.8

 
$
122.0

 
$
127.2

 
$
119.5

 
$
467.2

B
Pretax costs incurred (or anticipated to be incurred, as applicable) for transaction costs deemed significant and integration preparation costs in the three-month period ended September 27, 2019 ($30 million pretax as reported in this line item, $28 million after-tax), the three-month period ended June 28, 2019 ($18 million pretax as reported in this line item, $16 million after-tax), the three-month period ended March 29, 2019 ($15 million pretax as reported in this line item, $13 million after-tax) and the nine-month period ended September 27, 2019 ($63 million pretax as reported in this line item, $57 million after-tax) related to the anticipated GE Biopharma acquisition. The Company deems acquisition-related transaction costs incurred in a given period to be significant (generally relating to the Company’s larger acquisitions) if it determines that such costs exceed the range of acquisition-related transaction costs typical for Danaher in a given period.
C
Acquisition-related transaction costs deemed significant ($15 million pretax as reported in this line item, $13 million after-tax), and fair value adjustments to inventory ($1 million pretax as presented in this line item, $0.8 million after-tax), in each case related to the acquisition of IDT and incurred in the second quarter of 2018.
D
Net gains on resolution of acquisition-related matters in the Life Sciences segment ($9 million pretax as reported in this line item, $7 million after-tax) for the second quarter of 2018 and net gains on resolution of acquisition-related matters in the Life Sciences and Diagnostics segments ($11 million pretax as presented in this line item, $8 million after-tax) for the year ended December 31, 2017.
E
Gain on sales of investments in the year ended December 31, 2017 ($73 million pretax as presented in this line item, $46 million after-tax).
F
During 2017, the Company recorded $76 million of pretax restructuring, impairment and other related charges ($51 million after-tax) primarily related to the Company’s strategic decision to discontinue certain product development efforts in its Diagnostics segment. As a result, the Company incurred noncash charges for the impairment of certain technology-related intangibles as well as related inventory and plant, property, and equipment with no further use totaling $49 million. In addition, the Company incurred cash restructuring costs primarily related to employee severance and related charges totaling $27 million. Additional information regarding the exclusion of this item is set forth in the “Statement Regarding Non-GAAP Measures.”
G
This line item reflects the aggregate tax effect of all nontax adjustments reflected in the preceding line items of the table. In addition, the footnotes above indicate the after-tax amount of each individual adjustment item. Danaher estimates the tax effect of each adjustment item by applying Danaher’s overall estimated effective tax rate to the pretax amount, unless the nature of the item and/or the tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment, in which case the tax effect of such item is estimated by applying such specific tax rate or tax treatment. The MCPS dividends are not tax deductible and therefore the tax effect of the adjustments does not include any tax impact of the MCPS dividends.
H
Discrete tax matters relate primarily to changes in estimates associated with prior period uncertain tax positions and audit settlements, net of the release of valuation allowances associated with certain foreign tax credits and tax benefits resulting from a change in law. The Company anticipates excess tax benefits from stock compensation of approximately $7 million per quarter and therefore excludes benefits in excess of this amount in the calculation of Adjusted Diluted Net Earnings Per Share. Discrete tax adjustments and other tax-related adjustments and the impact per diluted share, in each of the historic periods are as follows:
 
Nine-Month Period Ended
 
Three-Month Period Ended
 
Year Ended
 
Three-Month Period Ended
 
Year Ended
($ in millions, expect per share amounts)
Sep 27, 2019
 
Sep 27, 2019
 
Jun 28, 2019
 
Mar 29, 2019
 
Dec 31, 2018
 
Dec 31, 2018
 
Sep 28, 2018
 
Jun 29, 2018
 
Mar 30, 2018
 
Dec 31, 2017
Discrete tax charge (gain) including Envista
$
227.1

 
$
—

 
$
(15.4
)
 
$
242.5

 
$
(26.2
)
 
$
6.7

 
$
(23.5
)
 
$
(9.4
)
 
$
—

 
$
(146.5
)
Less Envista discrete tax charge (gain)
0.3

 
—

 
2.5

 
(2.2
)
 
9.4

 
9.5

 
0.1

 
(0.2
)
 
—

 
(9.6
)
Discrete tax charge (gain) from continuing operations excluding Envista
$
226.8

 
$
—

 
$
(17.9
)
 
$
244.7

 
$
(35.6
)
 
$
(2.8
)
 
$
(23.6
)
 
$
(9.2
)
 
$
—

 
$
(136.9
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Impact per diluted share from continuing operations excluding Envista
$
0.31

*
$
—

 
$
(0.02
)
 
$
0.34

 
$
(0.05
)
*
$
—

 
$
(0.03
)
 
$
(0.01
)
 
$
—

 
$
(0.19
)
* Quarterly amounts do not add across to the nine-month or year-ended amounts due to rounding.
I
In March 2019, the Company issued $1.65 billion in aggregate liquidation preference of our 4.75% MCPS. Dividends on the MCPS are payable on a cumulative basis at an annual rate of 4.75% on the liquidation preference of $1,000 per share. Unless earlier converted, each share of MCPS will automatically convert on April 15, 2022 into between 6.6382 and 8.1318 shares of Danaher’s common stock, subject to anti-dilution adjustments (including adjustments that will be made as a result of the disposition of Envista). The number of shares of Danaher’s common stock issuable on conversion of the MCPS will be determined based on the VWAP per share of our common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately before April 15, 2022. For the purposes of calculating adjusted pro forma diluted net earnings per share, the Company has excluded the anticipated MCPS cash dividends and assumed the “if-converted” method of share dilution (the incremental shares of common stock deemed outstanding applying the “if-converted” method of calculating share dilution are referred to as the “Converted Shares.”) The Company believes that using the “if-converted” method provides additional insight to investors on the anticipated impact of the MCPS once they are converted into common stock no later than April 15, 2022.

4

Table 3: Adjusted Average Diluted Common Shares Outstanding

 
Nine-Month Period Ended
 
Three-Month Period Ended
 
Year Ended
 
Three-Month Period Ended
 
Year Ended
(shares in millions)
Sep 27, 2019 1
 
Sep 27, 2019 1
 
Jun 28, 2019 1
 
Mar 29, 2019 1
 
Dec 31, 2018
 
Dec 31, 2018
 
Sep 28, 2018
 
Jun 29, 2018
 
Mar 30, 2018
 
Dec 31, 2017
Average common stock and common equivalent shares outstanding - diluted
725.2

 
729.3

 
727.9

 
718.5

 
710.2

 
711.2

 
710.6

 
709.5

 
709.5

 
706.1

Converted shares
9.3

 
11.6

 
11.9

 
4.3

 
—

 
—

 
—

 
—

 
—

 
—

Adjusted average common stock and common equivalent shares outstanding - diluted
734.5

 
740.9

 
739.8

 
722.8

 
710.2

 
711.2

 
710.6

 
709.5

 
709.5

 
706.1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 The number of converted shares assumes the conversion of all 1.65 million shares of common stock underlying the MCPS applying the "if-converted" method of accounting and using an average 20 trading-day trailing volume weighted average price ("VWAP") for each respective quarterly period of 2019.

Table 4: Pro Forma and Non-GAAP Pro Forma Sales, Operating Profit, Depreciation and Amortization By Segment

($ in millions)
Nine-Month Period Ended
 
Three-Month Period Ended 1
 
Year Ended
 
Three-Month Period Ended 1
 
Year Ended
Sales
Sep 27, 2019
 
Sep 27, 2019
 
Jun 28, 2019
 
Mar 29, 2019
 
Dec 31, 2018
 
Dec 31, 2018
 
Sep 28, 2018
 
Jun 29, 2018
 
Mar 30, 2018
 
Dec 31, 2017
Life Sciences
$
5,035.1

 
$
1,695.6

 
$
1,712.6

 
$
1,626.9

 
$
6,471.4

 
$
1,793.5

 
$
1,596.7

 
$
1,605.2

 
$
1,476.0

 
$
5,710.1

Diagnostics
4,757.0

 
1,601.9

 
1,618.3

 
1,536.8

 
6,257.6

 
1,684.5

 
1,502.5

 
1,550.9

 
1,519.7

 
5,839.9

Environmental & Applied Sciences
3,250.6

 
1,080.5

 
1,113.6

 
1,056.5

 
4,319.5

 
1,126.5

 
1,074.4

 
1,091.5

 
1,027.1

 
3,968.8

Total sales
$
13,042.7

 
$
4,378.0

 
$
4,444.5

 
$
4,220.2

 
$
17,048.5

 
$
4,604.5

 
$
4,173.6

 
$
4,247.6

 
$
4,022.8

 
$
15,518.8

Operating Profit
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Life Sciences
$
995.5

 
$
342.5

 
$
344.0

 
$
309.0

 
$
1,229.3

 
$
353.7

 
$
312.8

 
$
291.5

 
$
271.3

 
$
1,004.3

Diagnostics
782.0

 
266.0

 
282.9

 
233.1

 
1,073.8

 
316.4

 
235.1

 
274.3

 
248.0

 
871.6

Environmental & Applied Sciences
761.3

 
256.5

 
260.2

 
244.6

 
988.0

 
255.5

 
254.3

 
251.0

 
227.2

 
914.6

Other
(231.1
)
 
(88.7
)
 
(75.4
)
 
(67.0
)
 
(236.0
)
 
(62.2
)
 
(56.9
)
 
(57.9
)
 
(59.0
)
 
(218.2
)
Total operating profit
$
2,307.7

 
$
776.3

 
$
811.7

 
$
719.7

 
$
3,055.1

 
$
863.4

 
$
745.3

 
$
758.9

 
$
687.5

 
$
2,572.3

Depreciation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Life Sciences
$
96.8

 
$
31.7

 
$
32.8

 
$
32.3

 
$
127.4

 
$
32.6

 
$
32.6

 
$
31.6

 
$
30.6

 
$
119.0

Diagnostics
280.1

 
94.3

 
94.2

 
91.6

 
379.2

 
94.7

 
92.2

 
98.0

 
94.3

 
368.1

Environmental & Applied Sciences
36.6

 
11.6

 
12.6

 
12.4

 
47.0

 
12.2

 
11.0

 
12.1

 
11.7

 
43.4

Other
7.0

 
2.2

 
2.4

 
2.4

 
8.5

 
2.3

 
2.2

 
2.0

 
2.0

 
7.6

Total depreciation
$
420.5

 
$
139.8

 
$
142.0

 
$
138.7

 
$
562.1

 
$
141.8

 
$
138.0

 
$
143.7

 
$
138.6

 
$
538.1

Amortization
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Life Sciences
$
267.7

 
$
89.0

 
$
89.1

 
$
89.6

 
$
343.8

 
$
88.4

 
$
84.2

 
$
90.5

 
$
80.7

 
$
308.9

Diagnostics
155.1

 
51.3

 
51.8

 
52.0

 
209.8

 
52.0

 
52.1

 
52.6

 
53.1

 
213.4

Environmental & Applied Sciences
46.5

 
15.3

 
15.4

 
15.8

 
62.0

 
15.7

 
15.3

 
15.4

 
15.6

 
56.5

Total amortization
$
469.3

 
$
155.6

 
$
156.3

 
$
157.4

 
$
615.6

 
$
156.1

 
$
151.6

 
$
158.5

 
$
149.4

 
$
578.8

1 These quarterly results are not required under Article 11 of Regulation S-X and are therefore non-GAAP financial information. The quarterly results have been presented in a manner consistent with the Article 11 Pro Forma Financial Statements.



5

Table 5: Non-GAAP Core Revenue Growth From Continuing Operations Excluding Envista
 
% Change vs Comparable Period in Prior Year
 
Nine-Month Period Ended
 
Three-Month Period Ended
 
Year Ended
 
Three-Month Period Ended
 
Year Ended
 
Sep 27, 2019
 
Sep 27, 2019
 
Jun 28, 2019
 
Mar 29, 2019
 
Dec 31, 2018
 
Dec 31, 2018
 
Sep 28, 2018
 
Jun 29, 2018
 
Mar 30, 2018
 
Dec 31, 2017
Total sales growth from continuing operations excluding Envista
5.0%
 
5.0%
 
4.5%
 
5.0%
 
10.0%
 
6.5%
 
9.0%
 
11.5%
 
13.5%
 
10.0%
Less the impact of:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acquisitions
(1.5)%
 
(0.5)%
 
(1.0)%
 
(3.0)%
 
(2.0)%
 
(2.5)%
 
(2.5)%
 
(2.5)%
 
(1.0)%
 
(6.0)%
Currency exchange rates
2.5%
 
1.5%
 
3.0%
 
4.0%
 
(1.0)%
 
2.0%
 
1.0%
 
(2.5)%
 
(5.5)%
 
—%
Core revenue growth from continuing operations excluding Envista (Non-GAAP)
6.0%
 
6.0%
 
6.5%
 
6.0%
 
7.0%
 
6.0%
 
7.5%
 
6.5%
 
7.0%
 
4.0%
Core revenue growth including Envista as historically reported (Non-GAAP)
5.5%
 
5.0%
 
5.5%
 
5.5%
 
6.0%
 
5.5%
 
6.5%
 
6.0%
 
5.5%
 
3.5%
Impact of Envista on Danaher’s core revenue growth as historically reported (Non-GAAP)
0.5%
 
1.0%
 
1.0%
 
0.5%
 
1.0%
 
0.5%
 
1.0%
 
0.5%
 
1.5%
 
0.5%
Core revenue growth from continuing operations excluding Envista (Non-GAAP)
6.0%
 
6.0%
 
6.5%
 
6.0%
 
7.0%
 
6.0%
 
7.5%
 
6.5%
 
7.0%
 
4.0%
Life Sciences
7.0%
 
6.5%
 
7.5%
 
7.0%
 
7.5%
 
7.5%
 
9.5%
 
7.5%
 
5.5%
 
4.0%
Diagnostics
7.0%
 
8.0%
 
7.5%
 
5.0%
 
6.5%
 
6.0%
 
5.5%
 
5.0%
 
9.5%
 
4.0%
Environmental & Applied Sciences
4.0%
 
2.0%
 
4.0%
 
5.5%
 
6.0%
 
5.0%
 
8.0%
 
7.0%
 
4.5%
 
4.0%
Danaher core revenue growth from continuing operations excluding Envista (Non-GAAP)
6.0%
 
6.0%
 
6.5%
 
6.0%
 
7.0%
 
6.0%
 
7.5%
 
6.5%
 
7.0%
 
4.0%

We use the term “core revenue” to refer to GAAP revenue excluding (1) sales from acquired businesses recorded prior to the first anniversary of the acquisition less the amount of sales attributable to divested businesses or product lines not considered discontinued operations (“acquisitions”) and (2) the impact of currency translation. The portion of GAAP revenue attributable to currency translation is calculated as the difference between (a) the period-to-period change in revenue (excluding acquisition sales) and (b) the period-to-period change in revenue (excluding acquisition sales) after applying current period foreign exchange rates to the prior year period. We use the term “core revenue growth” to refer to the measure of comparing current period core revenue with the corresponding period of the prior year.

6

Table 6: Fourth Quarter and Full Year 2019 Revised Forecasted Earnings Guidance 1 
The following table reflects the impact of treating Envista as a discontinued operation on our previously communicated earnings guidance.
 
 Three-Month
Period Ending
 
 Year Ending
 
 
December 31, 2019 2
 
December 31, 2019 2
 
 
Low End
 
High End
 
Low End
 
High End
 
Forecasted Diluted Net Earnings Per Common Share Including Envista (GAAP)
$
1.06

 
$
1.09

 
$
3.38

 
$
3.41

 
Anticipated pretax amortization of acquisition-related intangible assets A
0.23

 
0.23

 
0.96

 
0.96

 
Pretax Envista separation costs and costs related to establishing a new separate company infrastructure in connection with the Envista initial public offering, primarily related to incremental salaries, benefits and rent expense B
—

 
—

 
0.06

 
0.06

 
Anticipated pretax transaction costs deemed significant and integration preparation costs related to the anticipated GE Biopharma acquisition C
0.06

 
0.06

 
0.15

 
0.15

 
First quarter 2019 costs and estimated liabilities related to a legal contingency D
—

 
—

 
0.05

 
0.05

 
Early extinguishment of debt E
0.01

 
0.01

 
0.01

 
0.01

 
Tax effect of all adjustments reflected above F
(0.05
)
 
(0.05
)
 
(0.22
)
 
(0.22
)
 
Discrete tax adjustments and other tax-related adjustments G
—

 
—

 
0.31

 
0.31

 
Declared and anticipated dividends on the MCPS assuming “if-converted” method H
0.01

 
0.01

 
0.04

 
0.04

 
Forecasted Adjusted Diluted Net Earnings Per Common Share Including Envista (Non-GAAP)
$
1.32

 
$
1.35

 
$
4.74

 
$
4.77

 
Less impact of Envista from all periods 3
(0.08
)
 
(0.09
)
 
(0.37
)
 
(0.38
)
 
Forecasted Adjusted Diluted Net Earnings Per Common Share From Continuing Operations Excluding Envista (Non-GAAP)
$
1.24

 
$
1.26

 
$
4.37

*
$
4.39

*
 
 
 
 
 
 
 
 
 
1  The forward-looking estimates set forth above do not reflect future gains and charges that are inherently difficult to predict and estimate due to their unknown timing, effect and/or significance, such as certain future gains or losses on the sale of investments, acquisition or divestiture-related gains or charges and discrete tax items.
2  Each of the per share amounts above was calculated assuming MCPS had been converted into shares of common stock.
3  The fourth quarter impact of Envista is based on Envista’s fourth quarter 2019 forecasted net earnings guidance as publicly disclosed by Envista on October 24, 2019. The impact of Envista for the year ending December 31, 2019 is based on Envista’s historical reported results for the nine-month period ended September 27, 2019 plus Envista’s fourth quarter 2019 forecasted net earnings guidance as publicly disclosed by Envista on October 24, 2019.
* Quarterly amounts do not add to the forecasted year-ended amounts due to rounding.
A  Amortization of acquisition-related intangible assets in the following forecasted periods ($ in millions) (only the pretax amounts set forth below are reflected in the amortization line item above):
 
 
 
 
 
Forecasted #
 
Three-Month
 
Nine-Month
 
Three-Month
 
 
 
Period Ended
 
 Period Ended
 
Period Ending
 
Year Ending
 
September 27, 2019
 
December 31, 2019
Pretax amortization including Envista
$
177.9

 
$
536.6

 
$
173.7

 
$
710.3

After-tax amortization including Envista
143.2

 
430.9

 
139.5

 
570.4

# Forecasted amortization of acquisition-related intangibles from continuing operations is $151.3 million pretax ($121.6 million after-tax) for the three-month period ending December 31, 2019 and $620.6 million pretax ($499.0 million after-tax) for the year ending December 31, 2019. 
B  Pretax costs incurred in the three-month period ended September 27, 2019, ($25 million pretax as reported in this line item, $22 million after-tax), the nine-month period ended September 27, 2019, and year ending December 31, 2019, ($47 million pretax as reported in this line item, $41 million after-tax) related to preparation for the Envista separation and initial public offering primarily related to professional fees for legal, tax, finance and information technology services and duplicative general and administrative costs related to establishing a public company infrastructure for the business including incremental salaries, benefits and rent expense.
C  Pretax costs incurred (or anticipated to be incurred, as applicable) for transaction costs deemed significant and integration preparation costs in the three-month period ended September 27, 2019, ($30 million pretax as reported in this line item, $28 million after-tax), the nine-month period ended September 27, 2019, ($63 million pretax as reported in this line item, $57 million after-tax), the three-month period ending December 31, 2019, ($49 million pretax as reported in this line item, $43 million after-tax) and the year ending December 31, 2019, ($112 million pretax as reported in this line item, $100 million after-tax) related to the anticipated GE Biopharma acquisition. The Company deems acquisition-related transaction costs incurred in a given period to be significant (generally relating to the Company’s larger acquisitions) if it determines that such costs exceed the range of acquisition-related transaction costs typical for Danaher in a given period.
D  Provision for potential costs and liabilities in connection with a legal contingency ($36 million pretax as reported in this line item, $29 million after-tax) recorded in the first quarter of 2019.
E  Loss on early extinguishment of debt resulting from "make-whole" payments associated with the retirement of the 2020 U.S. Notes and the 2020 Assumed Pall Notes ($7 million pretax as reported in this line item, $5 million after-tax) in the three-month period ending December 31, 2019.
F  This line item reflects the aggregate tax effect of all nontax adjustments reflected in the preceding line items of the table. In addition, the footnotes above indicate the after-tax amount of each individual adjustment item. Danaher estimates the tax effect of each adjustment item by applying Danaher’s overall estimated effective tax rate to the pretax amount, unless the nature of the item and/or the tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment, in which case the tax effect of such item is estimated by applying such specific tax rate or tax treatment. The MCPS dividends are not tax deductible and therefore the tax effect of the adjustments does not include any tax impact of the MCPS dividends.

7

G  Discrete tax adjustments and other tax-related adjustments for the nine-month period ended September 27, 2019, includes the impact of net discrete tax charges of $227 million or $0.31 per diluted share. The discrete tax matters relate primarily to changes in estimates associated with prior period uncertain tax positions and audit settlements, net of the release of valuation allowances associated with certain foreign tax credits and tax benefits resulting from a change in law. The Company anticipates excess tax benefits from stock compensation of approximately $7 million per quarter and therefore excludes benefits in excess of this amount in the calculation of Adjusted Diluted Net Earnings Per Share.
H In March 2019, the Company issued $1.65 billion in aggregate liquidation preference of our 4.75% MCPS. Dividends on the MCPS are payable on a cumulative basis at an annual rate of 4.75% on the liquidation preference of $1,000 per share. Unless earlier converted, each share of MCPS will automatically convert on April 15, 2022 into between 6.6382 and 8.1318 shares of Danaher’s common stock, subject to anti-dilution adjustments (including adjustments that will be made as a result of disposition of Envista). The number of shares of Danaher’s common stock issuable on conversion of the MCPS will be determined based on the VWAP per share of our common stock over the 20 consecutive trading day period beginning on, and including, the 21st scheduled trading day immediately before April 15, 2022. For the purposes of calculating forecasted adjusted earnings per share, the Company has excluded the anticipated MCPS cash dividends and assumed the “if-converted” method of share dilution (the incremental shares of common stock deemed outstanding applying the “if-converted” method of calculating share dilution are referred to as the “Converted Shares.”) The Company believes that using the “if-converted” method provides additional insight to investors on the anticipated impact of the MCPS once they are converted into common stock no later than April 15, 2022.

8

Statement Regarding Non-GAAP Measures
Each of the non-GAAP measures set forth above should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies. Management believes that these measures provide useful information to investors by offering additional ways of viewing Danaher’s results that, when reconciled to the corresponding GAAP measure, help our investors to (1) understand the long-term profitability trends of our business and compare our profitability to prior and future periods and to our peers, and (2) identify underlying growth trends in our business and compare our revenue performance with prior and future periods and to our peers.
Management uses non-GAAP earnings per share-related measures and core revenue-related measures to measure the Company’s operating and financial performance and as performance measures in the Company’s executive compensation program.
The items excluded from the non-GAAP measures set forth above have been excluded for the following reasons:
•
We exclude the impact of Envista because Envista is no longer part of Danaher, and showing Danaher’s historical results on a basis that excludes Envista provides investors useful information regarding Danaher’s future prospects without Envista.
•
We exclude the amortization of acquisition-related intangible assets from the calculation of non-GAAP earnings per share-related measures because the amount and timing of such charges are significantly impacted by the timing, size, number and nature of the acquisitions we consummate. While we have a history of significant acquisition activity we do not acquire businesses on a predictable cycle, and the amount of an acquisition’s purchase price allocated to intangible assets and related amortization term are unique to each acquisition and can vary significantly from acquisition to acquisition. Exclusion of this amortization expense facilitates more consistent comparisons of operating results over time between our newly acquired and long-held businesses, and with both acquisitive and non-acquisitive peer companies. We believe however that it is important for investors to understand that such intangible assets contribute to revenue generation and that intangible asset amortization related to past acquisitions will recur in future periods until such intangible assets have been fully amortized.
•
We exclude costs incurred pursuant to discrete restructuring plans that are fundamentally different (in terms of the size, strategic nature and planning requirements, as well as the inconsistent frequency, of such plans) from the ongoing productivity improvements that result from application of the Danaher Business System. Because these restructuring plans are incremental to the core activities that arise in the ordinary course of our business and we believe are not indicative of Danaher’s ongoing operating costs in a given period, we exclude these costs from the calculation of non-GAAP earnings per share-related measures to facilitate a more consistent comparison of operating results over time.
•
Danaher’s Mandatory Convertible Preferred Stock (“MCPS”) will mandatorily convert into Danaher common stock on the mandatory conversion date, which is expected to be April 15, 2022 (unless converted or redeemed earlier in accordance with the terms of the applicable certificate of designations). On the prior pages, we present the earnings per share-related measures on a basis which assumes the MCPS had already been converted as of the beginning of the applicable period (and accordingly also exclude the dividends that were actually paid on the MCPS during such period, since such dividends would no longer be paid once the MCPS convert). We believe this presentation provides useful information to investors by helping them understand what the net impact will be on Danaher’s earnings per share-related measures once the MCPS convert into Danaher common stock.
•
With respect to the other items excluded from non-GAAP earnings per share-related measures, we exclude these items because they are of a nature and/or size that occur with inconsistent frequency, occur for reasons that may be unrelated to Danaher’s commercial performance during the period and/or we believe that such items may obscure underlying business trends and make comparisons of long-term performance difficult.
•
With respect to core revenue-related measures, (1) we exclude the impact of currency translation because it is not under management’s control, is subject to volatility and can obscure underlying business trends, and (2) we exclude the effect of acquisitions and divested product lines because the timing, size, number and nature of such transactions can vary significantly from period-to-period and between us and our peers, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult.


9
 EX-101.SCH 3 dhr-20191218.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001000 - Document - Cover Page Document link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 4 dhr-20191218_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 5 dhr-20191218_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 6 dhr-20191218_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover Page [Abstract] Cover Page [Abstract] Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre-commencement Tender Offer Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Entity Listings [Table] Entity Listings [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Stock [Member] Common Stock [Member] Preferred Stock [Member] Preferred Stock [Member] Floating Rate Senior Notes Due 2022 [Member] Floating Rate Senior Notes Due 2022 [Member] Floating Rate Senior Notes Due 2022 Member [Member] 1.7% Senior Notes Due 2022 [Member] 1.7% Senior Notes Due 2022 [Member] 1.7% Senior Notes Due 2022 [Member] 2.5% Senior Notes Due 2025 [Member] 2.5% Senior Notes Due 2025 [Member] 2.5% Senior Notes Due 2025 [Member] 0.2% Senior Notes Due 2026 [Member] 0.2% Senior Notes Due 2026 [Member] 0.2% Senior Notes Due 2026 [Member] 1.2% Senior Notes Due 2027 [Member] 1.2% Senior Notes Due 2027 [Member] 1.2% Senior Notes Due 2027 [Member] 0.45% Senior Notes Due 2028 [Member] 0.45% Senior Notes Due 2028 [Member] 0.45% Senior Notes Due 2028 [Member] 0.75% Senior Notes Due 2031 [Member] 0.75% Senior Notes Due 2031 [Member] 0.75% Senior Notes Due 2031 [Member] 1.35% Senior Notes Due 2039 [Member] 1.35% Senior Notes Due 2039 [Member] 1.35% Senior Notes Due 2039 [Member] 1.8% Senior Notes Due 2049 [Member] 1.8% Senior Notes Due 2049 [Member] 1.8% Senior Notes Due 2049 [Member] Entity Listings [Line Items] Entity Listings [Line Items] Amendment Flag Amendment Flag Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Central Index Key Entity Central Index Key EX-101.PRE 7 dhr-20191218_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 8 dhrlogofor8ksa34.jpg GRAPHIC begin 644 dhrlogofor8ksa34.jpg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end EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 12 97 1 false 11 0 false 0 false false R1.htm 0001000 - Document - Cover Page Document Sheet http://www.danaher.com/role/CoverPageDocument Cover Page Document Cover 1 false false All Reports Book All Reports newdhr8-k.htm dhr-20191218.xsd dhr-20191218_cal.xml dhr-20191218_def.xml dhr-20191218_lab.xml dhr-20191218_pre.xml ex991-unauditedproform.htm dhrlogofor8ksa34.jpg http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 12 0000313616-19-000176-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000313616-19-000176-xbrl.zip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end XML 13 newdhr8-k_htm.xml IDEA: XBRL DOCUMENT 0000313616 2019-12-18 2019-12-18 0000313616 dhr:A1.35SeniorNotesDue2039Member 2019-12-18 2019-12-18 0000313616 dhr:A2.5SeniorNotesDue2025Member 2019-12-18 2019-12-18 0000313616 dhr:A0.45SeniorNotesDue2028Member 2019-12-18 2019-12-18 0000313616 us-gaap:PreferredStockMember 2019-12-18 2019-12-18 0000313616 dhr:A1.8SeniorNotesDue2049Member 2019-12-18 2019-12-18 0000313616 us-gaap:CommonStockMember 2019-12-18 2019-12-18 0000313616 dhr:A1.7SeniorNotesDue2022Member 2019-12-18 2019-12-18 0000313616 dhr:A1.2SeniorNotesDue2027Member 2019-12-18 2019-12-18 0000313616 dhr:A0.75SeniorNotesDue2031Member 2019-12-18 2019-12-18 0000313616 dhr:FloatingRateSeniorNotesDue2022Member 2019-12-18 2019-12-18 0000313616 dhr:A0.2SeniorNotesDue2026Member 2019-12-18 2019-12-18 false 0000313616 8-K 2019-12-18 DANAHER CORPORATION DE 001-08089 59-1995548 2200 Pennsylvania Avenue, NW 20037-1701 Suite 800W Washington, DC 202 828-0850 false false false false Common stock, $0.01 par value DHR NYSE 4.75% Mandatory Convertible Preferred Stock, Series A, without par value DHR.PRA NYSE Floating Rate Senior Notes due 2022 DHR F 06/30/22 NYSE 1.700% Senior Notes due 2022 DHR 1.7 01/04/22 NYSE 2.500% Senior Notes due 2025 DHR 2.5 07/08/25 NYSE 0.200% Senior Notes due 2026 DHR 0.2 03/18/26 NYSE 1.200% Senior Notes due 2027 DHR 1.2 06/30/27 NYSE 0.450% Senior Notes due 2028 DHR 0.45 03/18/28 NYSE 0.750% Senior Notes due 2031 DHR 0.75 09/18/31 NYSE 1.350% Senior Notes due 2039 DHR 1.35 09/18/39 NYSE 1.800% Senior Notes due 2049 DHR 1.8 09/18/49 NYSE false XML 14 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 15 R1.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Cover Page Document
Dec. 18, 2019
Cover Page [Abstract]  
Document Type 8-K
Document Period End Date Dec. 18, 2019
Entity Registrant Name DANAHER CORPORATION
Entity Incorporation, State or Country Code DE
Entity File Number 001-08089
Entity Tax Identification Number 59-1995548
Entity Address, Address Line One 2200 Pennsylvania Avenue, NW
Entity Address, Address Line Two Suite 800W
Entity Address, City or Town Washington,
Entity Address, State or Province DC
Entity Address, Postal Zip Code 20037-1701
City Area Code 202
Local Phone Number 828-0850
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Listings [Line Items]  
Amendment Flag false
Entity Central Index Key 0000313616
Common Stock [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security Common stock, $0.01 par value
Trading Symbol DHR
Security Exchange Name NYSE
Preferred Stock [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 4.75% Mandatory Convertible Preferred Stock, Series A, without par value
Trading Symbol DHR.PRA
Security Exchange Name NYSE
Floating Rate Senior Notes Due 2022 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security Floating Rate Senior Notes due 2022
Trading Symbol DHR F 06/30/22
Security Exchange Name NYSE
1.7% Senior Notes Due 2022 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 1.700% Senior Notes due 2022
Trading Symbol DHR 1.7 01/04/22
Security Exchange Name NYSE
2.5% Senior Notes Due 2025 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 2.500% Senior Notes due 2025
Trading Symbol DHR 2.5 07/08/25
Security Exchange Name NYSE
0.2% Senior Notes Due 2026 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 0.200% Senior Notes due 2026
Trading Symbol DHR 0.2 03/18/26
Security Exchange Name NYSE
1.2% Senior Notes Due 2027 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 1.200% Senior Notes due 2027
Trading Symbol DHR 1.2 06/30/27
Security Exchange Name NYSE
0.45% Senior Notes Due 2028 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 0.450% Senior Notes due 2028
Trading Symbol DHR 0.45 03/18/28
Security Exchange Name NYSE
0.75% Senior Notes Due 2031 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 0.750% Senior Notes due 2031
Trading Symbol DHR 0.75 09/18/31
Security Exchange Name NYSE
1.35% Senior Notes Due 2039 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 1.350% Senior Notes due 2039
Trading Symbol DHR 1.35 09/18/39
Security Exchange Name NYSE
1.8% Senior Notes Due 2049 [Member]  
Entity Listings [Line Items]  
Title of 12(b) Security 1.800% Senior Notes due 2049
Trading Symbol DHR 1.8 09/18/49
Security Exchange Name NYSE

JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "newdhr8-k.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 12, "dts": { "calculationLink": { "local": [ "dhr-20191218_cal.xml" ] }, "definitionLink": { "local": [ "dhr-20191218_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "newdhr8-k.htm" ] }, "labelLink": { "local": [ "dhr-20191218_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "dhr-20191218_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "dhr-20191218.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 39, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 97, "memberCustom": 9, "memberStandard": 2, "nsprefix": "dhr", "nsuri": "http://www.danaher.com/20191218", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "newdhr8-k.htm", "contextRef": "D2019Q1FileDate", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Cover Page Document", "role": "http://www.danaher.com/role/CoverPageDocument", "shortName": "Cover Page Document", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "newdhr8-k.htm", "contextRef": "D2019Q1FileDate", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 11, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityListingsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Listings [Line Items]", "terseLabel": "Entity Listings [Line Items]" } } }, "localname": "EntityListingsLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "stringItemType" }, "dei_EntityListingsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container for exchange listing information for an entity", "label": "Entity Listings [Table]", "terseLabel": "Entity Listings [Table]" } } }, "localname": "EntityListingsTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "booleanItemType" }, "dhr_A0.2SeniorNotesDue2026Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.2% Senior Notes Due 2026 [Member]", "label": "0.2% Senior Notes Due 2026 [Member]", "terseLabel": "0.2% Senior Notes Due 2026 [Member]" } } }, "localname": "A0.2SeniorNotesDue2026Member", "nsuri": "http://www.danaher.com/20191218", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "domainItemType" }, "dhr_A0.45SeniorNotesDue2028Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.45% Senior Notes Due 2028 [Member]", "label": "0.45% Senior Notes Due 2028 [Member]", "terseLabel": "0.45% Senior Notes Due 2028 [Member]" } } }, "localname": "A0.45SeniorNotesDue2028Member", "nsuri": "http://www.danaher.com/20191218", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "domainItemType" }, "dhr_A0.75SeniorNotesDue2031Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "0.75% Senior Notes Due 2031 [Member]", "label": "0.75% Senior Notes Due 2031 [Member]", "terseLabel": "0.75% Senior Notes Due 2031 [Member]" } } }, "localname": "A0.75SeniorNotesDue2031Member", "nsuri": "http://www.danaher.com/20191218", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "domainItemType" }, "dhr_A1.2SeniorNotesDue2027Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.2% Senior Notes Due 2027 [Member]", "label": "1.2% Senior Notes Due 2027 [Member]", "terseLabel": "1.2% Senior Notes Due 2027 [Member]" } } }, "localname": "A1.2SeniorNotesDue2027Member", "nsuri": "http://www.danaher.com/20191218", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "domainItemType" }, "dhr_A1.35SeniorNotesDue2039Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.35% Senior Notes Due 2039 [Member]", "label": "1.35% Senior Notes Due 2039 [Member]", "terseLabel": "1.35% Senior Notes Due 2039 [Member]" } } }, "localname": "A1.35SeniorNotesDue2039Member", "nsuri": "http://www.danaher.com/20191218", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "domainItemType" }, "dhr_A1.7SeniorNotesDue2022Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.7% Senior Notes Due 2022 [Member]", "label": "1.7% Senior Notes Due 2022 [Member]", "terseLabel": "1.7% Senior Notes Due 2022 [Member]" } } }, "localname": "A1.7SeniorNotesDue2022Member", "nsuri": "http://www.danaher.com/20191218", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "domainItemType" }, "dhr_A1.8SeniorNotesDue2049Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "1.8% Senior Notes Due 2049 [Member]", "label": "1.8% Senior Notes Due 2049 [Member]", "terseLabel": "1.8% Senior Notes Due 2049 [Member]" } } }, "localname": "A1.8SeniorNotesDue2049Member", "nsuri": "http://www.danaher.com/20191218", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "domainItemType" }, "dhr_A2.5SeniorNotesDue2025Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2.5% Senior Notes Due 2025 [Member]", "label": "2.5% Senior Notes Due 2025 [Member]", "terseLabel": "2.5% Senior Notes Due 2025 [Member]" } } }, "localname": "A2.5SeniorNotesDue2025Member", "nsuri": "http://www.danaher.com/20191218", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "domainItemType" }, "dhr_CoverPageAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover Page [Abstract]", "label": "Cover Page [Abstract]" } } }, "localname": "CoverPageAbstract", "nsuri": "http://www.danaher.com/20191218", "xbrltype": "stringItemType" }, "dhr_FloatingRateSeniorNotesDue2022Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Floating Rate Senior Notes Due 2022 Member [Member]", "label": "Floating Rate Senior Notes Due 2022 [Member]", "terseLabel": "Floating Rate Senior Notes Due 2022 [Member]" } } }, "localname": "FloatingRateSeniorNotesDue2022Member", "nsuri": "http://www.danaher.com/20191218", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.danaher.com/role/CoverPageDocument" ], "xbrltype": "stringItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" }